Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
O2h Nominees Limited investment portfolio
O2h Nominees Limited has made numerous investments in companies such as Turbine Simulated Cell Technologies, Stratosvir, and Kuano within the Biotech sector.
unknown
Portfolio
5
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (5)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Kuano Ltd KUANO LTD is a drug discovery company that utilizes a quantum simulation platform combining quantum mechanics and artificial intelligence to design next-generation medicines, specifically focusing on developing enzyme inhibitors. Their target market includes pharmaceutical and biotech companies, for whom they develop pre-clinical drug candidates for challenging disease targets, including previously "undruggable" enzymes. | BiotechAIDeepTech | Confirmed | 2025-02-16 |
| Monument Therapeutics Limited | Healthcare & Life Sciences | Confirmed | 2026-02-21 |
Shareholding changes (6)
O2h Nominees Limited's positions across portfolio companies2026
- B ORDINARY SHARES 2,330 → 6,755
2025
- A2 ORDINARY 15,494 → 17,663
Articles (3)
- 3 Jun 2026
- 12 May 2026
- Turbine Simulated Cell Technologies raises £22.8m Series B for AI drug discovery platform9 May 2026Turbine Simulated Cell Technologies